Kenvue Inc.
Kenvue Inc. (KVUE) is a consumer health company with a $35.9B market cap, showing a strong evidentiary signal from a single director's $166.6M in concentrated insider buys and executive branch holdings by Donald J. Trump.
BusinessWhat KVUE does
Kenvue is a consumer health company spun off from Johnson & Johnson, operating in the over-the-counter (OTC) health products, skin health, and essential personal care segments. Its revenue is derived from the sale of branded consumer healthcare products globally. The company has no recorded federal contract revenue or direct lobbying spend.
12 months past · 3 months futureKVUE activity timeline
Executive Branch ConflictsKVUE held by Trump-administration officials
Lifetime Government AwardsKVUE federal contracts
KVUE doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding KVUE
Politicians Trading KVUEMembers of Congress with recent KVUE positions
Congressional TradesWho in Congress is trading KVUE
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting KVUELive legislation impacting this stock
Political ProfileWhere KVUE sits in Washington
[object Object]
STRUCTURAL: Minimal signals; no lobbying, donations, or federal contracts. EVIDENTIARY: Strong concentrated insider buying by Director Jeffrey C. Smith totaling $166.6M (`get_corporate_insider_signal.total_dollar_volume`). Executive branch exposure via Donald J. Trump's holdings in three separate disclosures (`get_executive_branch_exposure.by_ticker[0].holdings`). Net: Evidentiary signals dominate, pointing to high-conviction internal positioning.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
General healthcare sector legislative exposureU.S. Congress"`Recent bill_impacts` lists 8 healthcare bills with non-zero estimated revenue impacts."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Live signals + predictions for KVUE — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades KVUE
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord